Antonio Curti

机构：IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Istituto di Ematologia di Bologna · ORCID：0000-0002-7752-6049

发表论文 422 篇 · 总被引 8548 次 · h-index 45

代表论文

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet (2025 · Blood Advances · 被引 29)
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia (2024 · Nature Communications · 被引 23)
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial (2025 · Journal of Hematology & Oncology · 被引 16)
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients (2025 · Cancer Medicine · 被引 12)
Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program (2025 · Annals of Hematology · 被引 11)
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort (2025 · Journal of Hematology & Oncology · 被引 10)